Insider Selling: AdaptHealth (NASDAQ:AHCO) Insider Sells $113,426.50 in Stock

AdaptHealth Corp. (NASDAQ:AHCO) insider Russell Schuster III sold 11,275 shares of AdaptHealth stock in a transaction on Monday, June 1st. The stock was sold at an average price of $10.06, for a total value of $113,426.50. Following the transaction, the insider directly owned 136,538 shares of the company’s stock, valued at approximately $1,373,572.28. This represents a 7.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

AdaptHealth Stock Performance

Shares of AHCO stock opened at $9.89 on Friday. The stock has a fifty day moving average price of $11.50 and a 200 day moving average price of $10.55. The stock has a market cap of $1.34 billion, a PE ratio of -15.95, a P/E/G ratio of 0.49 and a beta of 1.47. AdaptHealth Corp. has a 1 year low of $8.06 and a 1 year high of $13.43. The company has a debt-to-equity ratio of 1.21, a quick ratio of 0.71 and a current ratio of 0.92.

AdaptHealth (NASDAQ:AHCO) last issued its quarterly earnings data on Tuesday, May 5th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by ($0.13). AdaptHealth had a positive return on equity of 2.76% and a negative net margin of 2.42%.The firm had revenue of $819.80 million for the quarter, compared to analyst estimates of $796.63 million. During the same period in the prior year, the firm posted ($0.05) earnings per share. The business’s revenue for the quarter was up 5.4% compared to the same quarter last year. Sell-side analysts forecast that AdaptHealth Corp. will post 0.44 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

AHCO has been the subject of several analyst reports. Robert W. Baird set a $18.00 target price on AdaptHealth in a research note on Wednesday, May 6th. UBS Group cut their price target on shares of AdaptHealth from $15.00 to $14.00 and set a “buy” rating on the stock in a report on Wednesday, May 6th. Wall Street Zen lowered AdaptHealth from a “buy” rating to a “hold” rating in a research note on Saturday. Jefferies Financial Group reiterated a “hold” rating and issued a $11.00 target price on shares of AdaptHealth in a research note on Monday, April 20th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of AdaptHealth in a report on Friday, May 22nd. Five investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $14.29.

Institutional Trading of AdaptHealth

A number of institutional investors and hedge funds have recently made changes to their positions in AHCO. Deerfield Management Company L.P. raised its position in shares of AdaptHealth by 15.9% during the 3rd quarter. Deerfield Management Company L.P. now owns 11,477,730 shares of the company’s stock worth $102,726,000 after purchasing an additional 1,572,835 shares during the period. Dimensional Fund Advisors LP increased its position in shares of AdaptHealth by 15.6% during the 3rd quarter. Dimensional Fund Advisors LP now owns 5,982,070 shares of the company’s stock valued at $53,537,000 after purchasing an additional 809,459 shares during the period. Reinhart Partners LLC. increased its position in shares of AdaptHealth by 10.6% during the 4th quarter. Reinhart Partners LLC. now owns 8,100,785 shares of the company’s stock valued at $80,684,000 after purchasing an additional 773,727 shares during the period. Kennedy Capital Management LLC increased its position in shares of AdaptHealth by 48.8% during the 3rd quarter. Kennedy Capital Management LLC now owns 2,090,138 shares of the company’s stock valued at $18,707,000 after purchasing an additional 685,554 shares during the period. Finally, Iron Triangle Partners LP increased its position in shares of AdaptHealth by 35.6% during the 4th quarter. Iron Triangle Partners LP now owns 2,609,003 shares of the company’s stock valued at $25,986,000 after purchasing an additional 684,871 shares during the period. 82.67% of the stock is currently owned by institutional investors and hedge funds.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.